Cel Sci CVM
NYSE CVM
$1.32 -0.09 (-6.45%)
As of: Nov 11, 2026 · 3:59 PM EST

Cel Sci (CVM) Revenue (2010 - 2026)

Updated

Cel Sci's Revenue was $17,389 in fiscal Q3 2017 (quarter ended Jun 30, 2017), down 86.6% from $129,975 a year earlier.

Analysis

Cel Sci (CVM) Revenue (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Revenue was $255,667 through Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Cel Sci 58.11 Mn 32.46 Mn - -110,240.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -110,240.00
Mar 31, 2026 -117,485.00
Dec 31, 2025 -87,789.00
Sep 30, 2025 -128,505.00
Jun 30, 2025 -172,050.00
Mar 31, 2025 -178,286.00
Dec 31, 2024 -170,103.00
Sep 30, 2024 -174,571.00
Jun 30, 2024 -190,705.00
Mar 31, 2024 -182,701.00
Dec 31, 2023 -197,696.00
Sep 30, 2023 -181,894.00
Jun 30, 2023 -181,670.00
Mar 31, 2023 159,063.00
Dec 31, 2022 -152,789.00
Sep 30, 2022 379,021.00
Jun 30, 2022 -913,193.00
Mar 31, 2022 -273,828.00
Dec 31, 2021 -273,034.00
Sep 30, 2021 -276,831.00
API Access

Cel Sci Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CVM&period=max&api_key=YOUR_API_KEY